⌘K

Home/Filings/4/0001415889-25-003366

4//SEC Filing

ANG ROBERT 4

Accession 0001415889-25-003366

CIK 0001817229other

View on SEC.gov Company Profile

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:36 PM ET

Size

4.8 KB

Accession

0001415889-25-003366

Insider Transaction Report

Form 4

Period: 2025-02-06

Vor Biopharma Inc.VOR

DirectorPRESIDENT AND CEO

Transactions

Tax Payment
Common Stock
2025-02-06$1.50/sh−2,787$4,181→ 918,952 total

Footnotes (1)

[F1]Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.

Documents

1 file

4
form4-02072025_090218.xmlPrimary

Issuer

Vor Biopharma Inc.

CIK 0001817229

Entity typeother

Related Parties

1

filerCIK 0001741283

Filing Metadata

Form type: 4
Filed: Feb 6, 7:00 PM ET
Accepted: Feb 7, 4:36 PM ET
Size: 4.8 KB

View on SEC.gov